Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer [Phase 4]

View source ↗

Summary

A Phase 4 study of Herceptin (trastuzumab) in combination with standard chemotherapy for HER2-positive metastatic gastric cancer was terminated, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Gastric Cancer | Phase 4 | Status: TERMINATED | Results posted: 2016-03-14